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 Abstract 
Escherichia coli O157:H7 has emerged as a significant human food-borne 
pathogen over the past two decades. While cattle have been identified as the major 
reservoir of the pathogen, the dynamics of shedding are still largely unknown. The role 
immunosuppression may play on fecal shedding in cattle is explored.  
The first study determined whether immunosuppression induced by 
dexamethasone injections affects the level and duration of fecal shedding of E. coli O157. 
Six one week old Holstein bull calves were injected intramuscularly with dexamethasone 
and orally inoculated with 109 CFU of a mixture of three nalidixic-acid resistant strains 
of E. coli O157. Another five one week old Holstein bull calves, only inoculated with the 
E. coli O157, served as controls. All calves were necropsied and samples from the 
gastrointestinal tract were cultured. Dexamethasone treated calves shed at higher levels 
on days four and seven post-inoculation, but not thereafter. The data from this study 
suggest that there may be a time dependent correlation between dexamethasone 
immunosuppression and the concentration of E. coli O157 an animal will shed in the 
feces and that transient immunosuppression does not result in prolonged shedding of E. 
coli O157. 
The goal of the second study was to determine whether calves immunosuppressed 
by persistent infection with bovine viral diarrhea virus (BVDV) will shed E. coli O157 at 
a higher level and for a longer duration than a normal animal. Nine six to eight week old 
calves persistently infected with non-cytopathic BVDV and eight normal calves obtained 
from separate cow-calf operations were orally inoculated with 109 CFU of a mixture five 
nalidixic-acid resistant strains of E. coli O157. All calves were necropsied and samples 
from the gastrointestinal tract cultured. There was no statistical difference in the 
concentration of E. coli O157 shed or the duration of shedding between the persistently 
infected BVDV calves and the control calves throughout the length of the study. The data 
suggest that immunosuppression caused by persistent infection with non-cytopathic 
 
BVDV infection does not play a role in the level or duration of shedding of E. coli 
O157:H7 in calves. 
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CHAPTER 1 - A Literature Review of Escherichia coli 
O157:H7 Fecal Shedding Patterns in the Bovine 
 
Introduction 
According to the Centers for Disease Control (CDC), Escherichia coli O157:H7 
causes about 73,000 human illnesses annually in the United States; of which 
approximately 2,000 result in hospitalization and 60 result in death (Frenzen, et al, 2005). 
Although Escherichia coli is a normal gastrointestinal inhabitant of mammals, there are 
several strains that are pathogenic. In 1982 a new pathogen was identified with two 
outbreaks of severe bloody diarrhea associated with a fast-food chain restaurant. This 
new pathogen was a strain of E. coli that expressed the somatic antigen (O) 157, the 
flagellar antigen (H) 7, and toxins similar to Shigella dysenteriae (Armstrong, et al, 
1996). E. coli O157:H7 has become a pathogen of significant public health concern, since 
it was first identified over two decades ago.  
Asymptomatic cattle have been identified as the primary reservoir of E. coli 
O157. For the most part, humans become infected with E. coli O157 by consuming food 
or water contaminated with feces, but also through direct contact with infected animals or 
humans (Armstrong, 1996). Human illness can range from transient diarrhea to severe 
bloody diarrhea, or secondary complications leading to death. It has been estimated that 
the annual cost of E. coli O157 illness in the United States is $405 million, including 
medical costs and lost productivity (Frenzen, et al, 2005). Therefore, it is important to 
evaluate the epidemiology of this organism to determine means of reducing the risk of 
human infection.   
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Epidemiology of E. coli O157 
Humans 
According to the Center for Disease Control’s (CDC) data from 10 states, in 2006 
there were 17,252 laboratory-confirmed cases of food borne illnesses. Of these, 590 were 
due to Escherichia coli O157:H7 (MMWR, 2007). In the 1996 FoodNet data from five 
states, of the 8,576 laboratory-confirmed cases of food borne illnesses,  340 were due to 
E. coli O157 (Wallace, et al, 2000). Therefore, there has not been a significant decrease 
in the number of cases of illness due to E. coli O157 in the last decade. This may be due 
to the fact that the number of sampling sites has doubled over the decade, there may be 
more awareness of the pathogen among laboratory sites (and more tests are performed to 
look for the pathogen in samples), and in 2001 the CDC introduced a new model to 
assess trends. The CDC reports that there was a significant decline in cases from 2002 to 
2004, most likely due to the implementation of Hazard Analysis and Critical Control 
Point (HACCP) protocols at slaughter plants by the United States Department of 
Agriculture – Food Safety and Inspection Service in 2002. However, there has been an 
increase in reported E. coli O157 infections since 2005, primarily associated with lettuce 
and bagged fresh spinach (MMWR, 2007).  
E. coli O157 is transmitted to humans by contaminated food and water 
consumption, from infected animal to person, and from infected person to person. 
Approximately 85% of E. coli infections are due to ingestion of contaminated foods 
(Frenzen, et al, 2005). In the United States, ingestion of undercooked ground beef has 
played a major role in outbreaks. Other food borne sources of E. coli O157 include roast 
beef, salami, mayonnaise, unpasteurized apple juice, unpasteurized milk, cantaloupe, 
grapes, alfalfa sprouts, potatoes, lettuce, and spinach (Armstrong, et al, 1996; MMWR, 
2007; Nataro and Kaper, 1998; Rangel, et al, 2005). Waterborne outbreaks have also 
been identified involving ingestion of drinking water or presumably swallowing of water 
during swimming in freshwater areas (Armstrong, et al, 1996; Rangel, et al, 2005). 
Outbreaks associated with animal contact are a newly recognized source of transmission. 
Contact with hide or environment contaminated with feces is the most likely mode of 
fecal-oral transmission (Keen, et al, 2006; Rangel, et al, 2005).  
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Infection with E. coli O157:H7 causes three primary syndromes in humans: 
hemorrhagic colitis, hemolytic uremic syndrome, and thrombotic thrombocytopenic 
purpura, as well as a variety of secondary clinical complications (Bach et al, 2002; Nataro 
and Kaper, 1998; Park et al, 1999). Symptoms of hemorrhagic colitis include abdominal 
cramps, bloody diarrhea, and dehydration lasting from two to nine days. Most illnesses 
are self-limiting but can become severe in children, elderly, and other 
immunocompromised individuals. Hemolytic uremic syndrome (HUS) symptoms include 
hemolytic anemia, thrombocytopenia, and acute renal failure. 85-95% of severe 
hemolytic-uremic syndrome in children in the United States is caused by E. coli 
O157:H7. Thrombotic thrombocytopenic purpure (TTP), in contrast to HUS, occurs in 
adults and involves neurological signs in addition to the hemolysis, thrombocytopenia, 
and renal failure (Armstrong et al, 1996; Bach et al, 2002; Nataro and Kaper, 1998; Park 
et al, 1999). 
Non-bovine and Bovine 
Although cattle are thought to be the most important reservoir for E. coli 
O157:H7, other animal reservoirs have been identified. In one study, fecal samples from 
several different farms were collected and E. coli O157 was detected from a horse, dogs, 
pooled bird samples, and pooled fly samples (Hancock et al, 1998). Sanderson et al 
(2006) were also able to collect positive samples from bird feces and flies. Doane et al 
(2007) collected positive samples from swine, turkeys, and chickens. One other study 
was able isolate E. coli O157 from wild bird feces (primarily gulls) collected along a 
shoreline and an urban landfill in England (Wallace et al, 1997). Another study detected 
E. coli O157 in the feces of free ranging sheep (Kudva et al, 1996). Free range deer have 
also been found to shed E. coli O157 in feces (Fischer et al, 2001; Sargeant et al, 1999). 
Over a one year period, Chapman et al (1997) were able to culture E. coli O157 from 
sheep and swine rectal fecal samples. While these studies indicate that E. coli O157 lacks 
host specificity, few animals other than cattle have been studied enough to determine 
their role in the spread of this human pathogen.   
Since non-bovine sources have been identified as a source of E. coli O157, 
environmental sources have also been investigated. Water samples have tested positive 
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for O15 in studies at the farm and feedlot levels (Hancock et al, 1998; Van Donkersgoed 
et al, 2001; Sanderson et al, 2006). Van Donkersgoed et al (2001) and Sanderson et al 
(2006) were able to obtain positive cultures from feed in feedbunks. Dodd et al (2003) 
sampled feed samples from feed bunks in 54 feedlots and found a prevalence of 14.9%. 
In a longitudinal study, environmental samples in a Kansas feedlot had a 0.7% prevalence 
of the bacteria prior to cattle entry. The environmental prevalence increased significantly 
to 17.1% after arrival of cattle, and positive samples were able to be obtained from 
lagoon water, bunk water, pen surfaces, pre-access and post-access feed at some point in 
the 13 week sampling time (Sanderson et al, 2006). In contrast, Hancock et al (1998) 
tested feed samples prior to being placed in the bunks and did not obtain any positive 
samples. One study examined how the moisture and manure content in feedlot pens affect 
the persistence of E. coli O157 in the environment. The conclusion was that as long as 
there was more than five percent manure on the ground of the pen with some amount of 
water, the bacteria either increased or persisted over the two week study period (Berry 
and Miller, 2005). These studies suggest that fecal contamination of the environment by 
cattle, and/or other animals (less likely), is important in the persistence of E. coli O157 in 
the environment and transmission among animals.  
Many studies have been done to determine the farm and feedlot prevalence of E. 
coli O157 among cattle in the United States. In a recent longitudinal study of four farms, 
3.4% of dairy cattle were determined to be shedding E. coli O157 (Doane et al, 2007). 
This is in contrast to an earlier study which determined a dairy herd prevalence of 1% 
(Hancock et al, 1997a). Doane et al (2007) also determined a prevalence of 4.7% in four 
beef herds, which is higher than the 1.9% (range of 0.7-2.3%) prevalence that Sargeant et 
al (2000) found. In a one time sampling of 15 herds from five different states, an average 
of 7.4% of beef calves at weaning time were shedding E. coli O157 in their feces 
(Laegreid et al, 1999). Sampling from 100 feedlots in 13 states, Hancock et al (1997b) 
found the prevalence to be 1.8% among animals, while a more recent study of 73 feedlots 
in four states had a 10.2% prevalence (Sargeant et al, 2003). Outside of the United States, 
there was a 1.9% prevalence in three Australian dairy herds (Cobbold and Desmarchelier, 
2000), a decrease from 10.6% in 1998 to 5.6% in 2000 on a Japanese dairy (Ezawa et al, 
2004), and an overall prevalence of 4.2% among different types of cattle herds in 
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England and Wales (Paiba et al, 2003). This prevalence data indicates that there is a 
similar distribution in several countries. Studies obtaining fecal samples at the slaughter 
plant had a prevalence that ranged from 7.5% in England (Omisakin et al, 2003) to 13% 
in Australia (Fegan et al, 2004). These studies indicate that E. coli O157 is present on 
nearly all cattle operations and is therefore ubiquitous among cattle populations.  
 
Factors Affecting Shedding Levels in the Bovine 
In order to better understand the epidemiology of E. coli O157:H7 in bovine 
populations, the duration and magnitude of fecal shedding, locations of possible 
persistent colonization within the gastrointestinal tract, as well as other factors need to be 
understood so that animals that could pose a greater risk of shedding can be identified. 
Duration of Fecal Shedding 
Several studies have been done where animals were individually inoculated with 
previously isolated E. coli O157 strains. Cray and Moon (1995) inoculated pre-weaned 3-
14 week old calves and adults with 1010 CFU and found them to be shedding for up to 14 
weeks post inoculation. Sanderson et al (1999) found that 1 week old calves inoculated 
with 108 CFU shed for a shorter period of time (20-43 days post inoculation) with the 
day to day shedding levels being variable. Weaned calves shed for a similar duration 
when inoculated with 1010 CFU and had a significant decrease in the magnitude shed 
during the first two weeks post-inoculation (Brown et al, 1997). Another study also 
looked at weaned calves but gave a significantly lower dose of inoculums (<300 and 
<1000 CFU) resulting in calves shedding transiently for at least 14 weeks (Besser et al, 
2001). A study in which 22 adult cattle were orally inoculated found three distinct 
patterns of shedding: those that stopped shedding by one week, those who shed for about 
one month (the majority of the animals), and those animals that shed for two months or 
longer. As in previous studies, all animals shed consistently for 7-10 days post 
inoculation and intermittently afterwards with no difference in shedding levels between 
the three groups (Grauke et al, 2002).  
Other studies have looked at naturally infected herds over a time period. One 
study found considerable variability in shedding among dairy farms that were tested 
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monthly for a year, with some herds having frequent positive samples and others rarely 
having positive samples. Overall, 63% of the animals shed E. coli O157 in the feces for 
less than one month (Besser et al, 1997). Khaitsa et al (2003) collected fecal samples 
weekly for 19 weeks, beginning at the time of arrival to the feedlot, and found three 
distinct phases in fecal shedding. The first eight weeks were termed the pre-epidemic 
period where there was a low pen prevalence in which infected cattle were shedding for a 
short duration (about two weeks). This was followed by an epidemic period (9-15 weeks 
post arrival), during which the pen prevalence was high and cattle shed for an average of 
four weeks. The final post-epidemic period (16-19 weeks post arrival) had medium pen 
prevalence and shedding duration decreased. 30% of the cattle were still shedding at the 
end of the study with a mean duration of three weeks. In contrast, Sanderson et al (2006) 
collected feedlot fecal and environmental samples prior to cattle entry and twice weekly 
for 11 weeks after cattle entry and obtained a significantly high pen prevalence three 
weeks after cattle entry.   
Gastrointestinal Tract Colonization 
Identifying the location of E. coli O157 is important in determining if there is a 
specific place where the bacteria replicate or persist in the bovine. Early studies narrowed 
the primary site of colonization to the proximal gastrointestinal tract. Specifically, one 
study found all weaned calves having positive cultures from the rumen and omasum and 
determined the primary site of localization as the forestomachs and proliferation of the 
bacteria within the ingesta (Brown et al, 1997). A later study found that while samples 
can be identified in the upper gastrointestinal tract, E. coli O157 does not stay there for 
long. It moves out of the duodenum within one hour of inoculation with 1010 CFU of E. 
coli O157 and is present in the feces within the colon within six hours post-inoculation 
(Grauke et al, 2002). Samples from slaughterhouse sampling found that detection in the 
colonic contents is more frequent than in the rumen. Furthermore, E. coli O157 in the 
rumen was associated with the rumen wall (Lave et al, 2003). This may suggest that the 
rumen wall may be a site of colonization, but the bacteria are cleared quickly from the 
rumenal contents and into the distal gastrointestinal tract, where it is detected with fecal 
sampling. Weaned calves that are fasted for 48 hours prior to inoculation and also receive 
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an immunosuppressive dose of dexamethasone had positive samples in the gallbladder 
(Stoffregen et al, 2004). Other studies have found positive samples in the gallbladder at 
slaughter, suggesting another possible site of colonization (Reinstein et al, 2007).  
Of more interest in the past few years has been the detection of E. coli O157 from 
a lymphoid rich region near the recto-anal junctional area (RAJ). This area was first 
identified by Naylor et al (2003) in weaned calves that were inoculated with 109 CFU 
and had been consistently shedding for at least 14 days post inoculation. All calves had 
positive fecal samples and high bacterial counts from colon and midrectum samples. In 
addition, five tissue samples proximal to the RAJ and one tissue sample at the RAJ were 
taken for testing. In 13 of the 15 animals that were still shedding two weeks after 
inoculation, the tissue samples immediately proximal to the RAJ had high bacterial 
counts. These animals also had higher bacterial counts in the feces compared to contents 
collected from elsewhere in the gastrointestinal tract. Further research has been 
conducted examining this RAJ location. Fecal samples and mucosal swab samples taken 
from 1cm and 15cm proximal to the RAJ immediately after slaughter indicated that high 
mucosal carriage (indicated as > 103 cfu/swab) were associated with high fecal 
concentration (indicated as > 103 cfu/g) (Low, et al, 2005). Another study obtained 
samples from three animals (two inoculated with 1010 CFU and one naturally infected) 
that had been consistently shedding E. coli O157 for at least two months. All three 
animals had positive recto-anal junction mucosal swab (RAMS) samples, however only 
one of the three animals had a positive fecal sample (Lim et al, 2007). Since there were 
two samples in this study that tested positively from the RAMS and not in the feces, it 
was suggested that RAMS is a more reliable technique for testing for E. coli O157 than 
fecal sampling. Cobbold et al (2007) collected RAMS and fresh fecal samples from a 
feedlot over a 14 week period and also found that RAMS samples were more sensitive 
than fecal sampling. 
Age 
Among animals that have been inoculated with the same dose, calves shed 
significantly higher numbers and for a longer time period than adults (Cray and Moon, 
1995). Among naturally infected calves of 1-10 months of age, calves that are 5-6 months 
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of age have a higher prevalence of shedding than the other ages (Widiasih et al, 2003). 
Hancock et al (1997a) determined that among dairy herds, weaned heifers had a higher 
prevalence than adults. Weight can be correlated with age in cattle and Dargatz et al 
(1997) found that among cattle entering the feedlot, pens that contained animals that 
weighed less than 700 pounds were more likely to culture positive for E. coli O157. 
Season 
Several studies have examined the prevalence and shedding levels of E. coli O157 
compared to the time of year but with conflicting results. Besser et al (1997) found that 
US dairy cattle shed less during the winter and spring and higher levels in the fall and 
summer. Smith et al (2005) also found higher prevalence during the summer than during 
the winter in US feedlots. In England and Japan, the highest shedding levels were also 
during the spring and summer (Chapman et al, 1997; Mechie, et al, 1997; Widiasih, et al, 
2003). Whether these seasonal changes are due to ambient temperature, moisture content, 
insect population, or other factors is unknown. Edrington et al (2006) found a higher 
correlation between length of daylight and prevalence (r=0.67) than temperature and 
prevalence (r=0.43). Using this hypothesis, a test group of commercial cattle were 
exposed to extended hours of light via artificial lighting. Only on one day did the test 
group have a higher fecal prevalence than the control group. Edrington et al (2007) also 
hypothesizes that the hormone triiodothyronine (T3) may play a role in the seasonal 
shedding patterns of E. coli O157 in cattle. However, further studies need to be done to 
replicate the findings.  
In contrast to the above studies, samples collected from a Scottish slaughter house 
found a higher prevalence during the cooler months when cattle are housed inside 
(11.2%) than during the warmer months (7.5%) (Ogden et al, 2004), suggesting that 
animal to animal contact in high density situations may play a role in the seasonal 
prevalence. Two studies conducted in the United States indicate that shedding is not 
season dependent. Samples collected from a Kansas feedlot from the middle of August to 
the end of February had the highest shedding prevalence in February and the second 
highest in August with no significant differences overall (Alam and Zurek, 2006). 
Another feedlot study conducted in North Dakota found the highest fecal prevalence in 
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March (Khaitsa et al, 2006). In this study, upon arrival to the feedlot in October, the fecal 
prevalence was 1.4%, which rose significantly to 6.9% 28 days later. The highest 
prevalence was 53% in March, which dropped in April to 21%. There were some 
management changes (rearrangement of animals into pens by weight and change in diet 
from a growing to finishing diet) between the November and March samplings which 
may have affected the prevalence more than season itself. However, the pens were also 
the muddiest during March due to melting of snow and ice, which could also have 
contributed to the greater prevalence. This is in agreement with Smith et al’s (2005) 
finding that the probability of a pen testing positive for E. coli O157 in the winter months 
was associated with the pen being wet and muddy.  
Type of Diet 
Two month old calves fed high roughage diets do not shed at higher levels or for 
longer than those fed a high concentrate diet and the rumenal populations of E. coli O157 
are no different in either group (Tkalcic et al, 2000). However, adults fed a complete hay 
diet (alfalfa or grass) shed for a longer duration than those fed a primarily grain diet 
(Hovde et al, 1999). The difference in findings between calves and adults may be due to 
the fact that calves do not have a fully developed and functioning rumen until about four 
months of age and are therefore unable to digest feeds in the same manner as adults. 
After examining 100 feedlots from 13 states, Dargatz et al (1997) determined that feedlot 
pens were more likely to culture positive for E. coli O157 if the feed contained barley 
(P=0.003), and pens were less likely to be positive if feed contained soybean meal 
(P=0.041). Buchko et al (2000) fed three different diets to three groups of yearling steers 
and inoculated them with 1010 CFU of an E. coli O157 strain and collected fecal samples 
for 10 weeks. The corn diet was 85% cracked corn and 15% alfalfa silage. The 
cottonseed and barley diet consisted of 15% whole cottonseed, 70% barley, and 15% 
alfalfa silage. The barley diet was 85% barley and 15% alfalfa silage. The steers were 
acclimated to the diets prior to inoculation. On days five and seven the corn group shed 
significantly lower levels of E. coli O157 than the other two groups. On day 49, both the 
corn and cottonseed with barley groups shed significantly less than the barley group and 
on day 63 the cottonseed with barley group shed less than the barley group. Overall, the 
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barley group had significantly more positive samples than the corn group (P<0.005) and 
the cottonseed with barley group (P<0.05). Although there was no difference in shedding 
levels between the groups on most days, Buchko et al determined that cattle fed a diet of 
primarily corn shed E. coli O157 fewer days than if fed primarily barley. A more recent 
study compared the effect canola oil added to either a barley or corn based diet would 
have after inoculation with E. coli O157 (Bach, et al, 2005). One group was fed a barley 
based diet with no canola oil, a second group was fed the same barley based diet with six 
percent canola oil, a third group was fed a corn based diet with no canola oil, and the 
fourth group was fed the same corn based diet with six percent canola oil. Adding the oil 
to the feed had no effect on shedding levels. Although there was no overall difference in 
shedding levels among the four treatment groups, there were significantly more positive 
samples obtained from the barley only group than the other three groups.  These studies 
suggest that feed type may have an effect on shedding levels, but the reasons for the 
difference are still not understood.  
Stress 
Cattle encounter stressful situations at various points in their life. During these 
time periods, there are immunological changes that occur in the body that allow them to 
be more susceptible to various infections which may lead to the increased shedding of 
organisms. 
Weaning in beef cattle often occurs between three and six months of age. In a 
longitudinal study examining 14 herds, Hancock et al (1997a) found that weaned heifers 
had a higher prevalence than unweaned calves or adults. Fasting can occur among cattle 
during the weaning period where the calf is transitioning from milk to roughage and/or 
grain diets as well as during transport. One week old calves that were fasted prior to and 
after a second inoculation and fasted after a third inoculation showed no difference in 
shedding levels (Sanderson et al, 1999). Weaned calves that are fasted after inoculation 
also show no difference in shedding levels in the feces or rumenal proliferation (Brown et 
al, 1997; Harmon et al, 1999).  In another study, there was no increase in shedding among 
three to four month old calves that were inoculated prior to having food withheld for 24 
hours. In contrast, if food was withheld for 48 hours prior to inoculation, they shed at 
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significantly higher levels (P=0.001) than those calves that had access to feed (Cray et al, 
1998).  
Several studies show that shipping of cattle does not increase E. coli O157 fecal 
shedding in cattle. Barham et al (2002) found that short term shipping of steers and 
heifers on trailers (30-40minutes) had no effect on shedding. Minihan et al (2003) 
followed cattle from the farm to the slaughter plant and found that the prevalence of E. 
coli O157 shedding in cattle sampled at the farm, post-transport to the slaughter facility, 
and once inside the slaughter facility was 18%, 13%, and 12% respectively. Carcasses 
were swabbed immediately following slaughter, and no positive samples were obtained. 
This study indicates that good hygienic practices at the slaughter facility are important in 
preventing food contamination.  
Bach et al (2004) found that non-preconditioned steer calves hauled for 15 hours 
did have a significantly higher level of E. coli O157 shedding, compared to 
preconditioned calves hauled 15 hours and compared to short haul calves (3 hours) that 
were either preconditioned or not preconditioned, suggesting that compounding stresses 
at one time, may cause an increase in shedding levels of E. coli O157.  
The prevalence of E. coli O157 was significantly lower in lactating dairy cows 
than in non-lactating cows, calves and heifers in one study (Mechie et al, 1997).  This 
study also found that shedding levels in lactating dairy cattle were highest during the first 
month post-partum, fell during the rest of lactation prior to another peak seven months 
into lactation.  In contrast, Edrington et al (2004) found that stage of lactation had no 
effect of the overall prevalence of dairy cows shedding E. coli O157.  
Re-infection / Re-inoculation 
Studies examining the effect re-inoculation of calves or adults with a similar or 
lower dose of E. coli O157 showed that the re-inoculated animals shed for a shorter 
duration or for about the same duration as those animals inoculated only one time (Cray 
and Moon, 1995; Grauke et al, 2002; Sanderson et al, 1999).  
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Definition of a “Super-shedder” 
The term “super-shedder,” has been coined for animals that shed E. coli O157 at 
higher levels and for a longer duration of time compared to other animals in the same 
location (Matthews et al, 2006). These animals may be important in the on-farm 
epidemiology, ecology, and shedding of E. coli O157 (Omisakin et al., 2003). As such, 
they may also play an important role in pre-harvest food safety. Modeling data suggests 
that the majority of transmission within a farm may be the result of a small number of 
these “super-shedders” resulting in elevated prevalence (Matthews, et al 2006). 
Therefore, determining the existence and what causes these “super-shedders” to shed at 
higher levels and/or for a longer duration is important. However, there are inconsistencies 
in the literature regarding the definition of what a “super-shedder” animal is. The 
thresholds for high level and long duration have seemingly been arbitrarily chosen in 
different studies.  
Besser et al (2001) classified calves that shed at greater than 1000 cfu/g feces as 
shedding high levels in their low dose inoculation study and noted marked variability in 
the level of shedding. When examining fecal versus RAMS samples for shedding, Low et 
al (2005) classified high shedders as animals that had greater than or equal to 103 cfu/g 
feces, whereas Naylor et al (2003) and Cobbold et al (2007) set the cutoff at 104 cfu/g 
feces.   
Lim et al (2007) determined shedding for greater than two months as a long 
duration of shedding. Naylor et al (2003) determined animals that shed for at least two 
weeks as being persistently infected. This definition seems inappropriate, since the 
majority of studies suggest fecal shedding of up to one month as being normal in either 
inoculated or naturally infected animals, and the majority of inoculated animals shed for 
greater than two weeks. Cobbold et al (2007) defined persistent shedding as having 
greater than 4 consecutive RAMS positive samples over a 14 week testing interval.  
Besser et al (1997) concluded that although fecal shedding is transient and of 
short duration in the majority of individuals, among herds that have high prevalence, 
there may be more likelihood of recurrent exposure leading to persistent shedding. 
Therefore, it needs to be determined whether some animals persistently shed E. coli O157 
because they remain colonized or because they are more susceptible to re-colonization.  
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Prevention and Control Methods 
Effectively reducing the fecal shedding of E. coli O157 in live-cattle would result 
in fewer human infections from contaminated foods according to a simulation study 
(Jordan et al, 1999). Ideally, this would be accomplished via two strategies: by decreasing 
the number of animals that shed the organism and by decreasing the number of organisms 
shed by an individual animal or a group of animals. Since the feces have been found to be 
a primary source of spread among cattle, proper sanitary management of the environment 
is of primary importance. Smith et al (2002) found that while scrubbing and disinfecting 
water tanks with chlorine substantially decreased the number of coliform bacteria in the 
tank initially, 24 hours after cleaning, bacterial counts were be back to pre-cleaning 
levels. Therefore, while proper cleaning methods are important to animal husbandry, it 
can be labor intensive and time consuming, and may only result in short term 
management of fecal contamination.  
Several studies have looked at alternative methods of reducing shedding of E. coli 
O157. Brashears et al (2003b) isolated several strains of lactic acid bacteria from the 
feces of cattle not shedding E. coli O157. Of all the strains isolated, 52% of the lactic acid 
bacterial isolates were able to inhibit E. coli O157 growth on media and significantly 
inhibited growth in colonic samples and rumen fluid in vitro. Two of the isolates, 
Lactobacillus acidophilus or Lactobacillus cristatus were then placed into the feed and 
water of cattle in a feedlot. Over time, animals that were given the Lactobacillus 
acidophilus were 49% less likely to shed E. coli O157 in the feces compared to a control 
group. At slaughter, hide samples were taken and animals that received either microbial 
agent had significantly lower hide prevalence than the control animals (Brashears et al, 
2003a).  
Rather than examining the use of competitive bacteria as a method of decreasing 
shedding in an animal, Dziva et al (2007) used a mutant form of E. coli O157 to examine 
whether colonization would be affected. Three 14 day old bull calves were inoculated 
with a wild type and three others were inoculated with a strain that had the EspA gene 
deleted. This gene allows the bacteria to form filamentous attachments to the 
gastrointestinal cells of the host. Results showed that animals that received the mutant 
strains shed significantly lower levels in the feces from day one post-inoculation and for a 
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shorter duration than the control animals. However, in the follow-up vaccination trial, 
when a purified version of the mutant strain was given three times intramuscularly and 
intranasal once to 14 day old bull calves, there was no difference in the levels or duration 
of shedding in the feces of vaccinated calves compared to the control calves.    
Potter et al (2004) examined the effect a different type of vaccine has on shedding 
prevalence. Based on the determination that certain proteins (Tir, EspA, and EspB) 
secreted by the type III system play a role in gastrointestinal tract colonization of non-
bovine hosts, vaccines were prepared using these proteins and given subcutaneously to 
cattle in three separate studies. In the first study, the test calves were vaccinated two 
weeks prior to inoculation with a 108 cfu dose of E. coli O157. Over a two week period, 
the vaccinated group shed less (P=0.05) than the control group that received an adjuvant. 
In the second study, the group of yearlings that received three doses of vaccines 49 days 
prior to inoculation shed less and for a shorter time than the non-vaccinated group. The 
last study showed that cattle receiving three doses of vaccine post-arrival to the feedlot 
shed less (P=0.04) than the control group.  
In calves challenged orally and rectally with E. coli O157, rectally administered 
polymyxin B (an antibiotic) and chlorahexidine gluconate (an antiseptic agent) treated 
animals shed significantly lower levels (P<0.001) of E. coli O157 in the feces than the 
control calves, with no difference seen between the two treatment types (Naylor et al, 
2007). A problem with this study was that animals were not evenly distributed into 
treatment groups, with significantly more being present in the chlorahexidine treatment 
groups.  
 
Conclusion 
E. coli O157 is ubiquitous among cattle populations in all aspects of the 
production system. Fecal shedding by cattle is currently thought to be the major route of 
spread to other cattle and to humans. However, there are still many factors that are not 
completely understood about the epidemiology of E. coli O157 in the bovine. One 
important aspect is being able to determine which animals are more likely to harbor the 
organism in their gastrointestinal tract and, consequently, are more likely to shed it. 
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Further research is needed to increase our knowledge about the dynamics of E. coli O157 
in the individual animal and in the herd in order to reduce the chances of it contaminating 
human foods.  
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CHAPTER 2 - Impact of Dexamethasone Induced 
Immunosuppression on the Duration and Level of Shedding of 
E. coli O157:H7 in CalvesChapter Title Here 
 
Abstract  
The goal of this study was to determine whether immunosuppression plays a role 
in the level and duration of fecal shedding of E. coli O157. Immunosuppression was 
induced in calves by administering dexamethasone. Six one week old Holstein bull calves 
were injected intramuscularly with dexamethasone and orally inoculated with 109 CFU 
of a mixture of three nalidixic-acid resistant strains of E. coli O157. Five one week old 
Holstein bull calves that were given the same oral inoculation of E. coli O157, but not the 
dexamethasone injections, served as controls. As expected, dexamethasone treatment 
induced a glucocorticoid leukogram on complete blood counts, confirming the 
immunosuppressive status in the dexamethasone calves. All calves were examined daily 
and fecal samples were collected three times a week for detection and enumeration of the 
nalidixic-acid resistant E. coli O157. Four weeks after the last calf stopped shedding, all 
calves were necropsied and samples from the gastrointestinal tract were taken for the 
detection of the nalidixic-acid resistant E. coli O157. Dexamethasone treated calves shed 
at higher levels (P value=0.038) on days four and seven post-inoculation, but not 
thereafter. No E. coli O157 was detected at necropsy. The data from this study suggest 
that there may be a time dependent correlation between dexamethasone 
immunosuppression and the concentration of E. coli O157 an animal will shed in the 
feces, that higher levels of E. coli O157 will be shed for as long as dexamethasone 
suppresses the immune system, and that transient immunosuppression does not result in 
prolonged shedding of E. coli O157. 
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Introduction 
Enterohemorrhagic Escherichi coli O157:H7 has emerged as a pathogen of public 
health significance over the past two decades. Although infected cattle are asymptomatic, 
infection can cause hemorrhagic colitis in humans. The colitis can be more severe in 
children, the elderly, and other immunocompromised individuals. E. coli O157:H7 is also 
the cause of 85-95 percent of severe hemolytic-uremic syndrome in children in the 
United States (Armstrong, et al., 1996). Several studies have indicated relatively high 
herd prevalence among farm and feedlot cattle and beef and beef products have been 
identified as a significant human source for the pathogen (Hancock, et al, 1998; Galland, 
et al 2001). 
Some researchers have proposed the presence of animals termed “super 
shedders,” which shed E. coli O157 at higher levels and for a longer duration of time 
compared to other animals in the same location. These animals may be important in the 
on-farm epidemiology, ecology, and shedding of E. coli O157 (Omisakin et al., 2003). As 
such, they may play an important role in pre-harvest food safety. Modeling data suggests 
that the majority of transmission within a farm is the result of a small number of these 
“super shedders” resulting in elevated prevalence (Matthews, et al 2006). Therefore, 
determining what causes these “super shedders” to shed at higher levels and/or for a 
longer duration is important. Stoffregen, et al (2004) used dexamethasone 
immunosuppression in a study of weaned calves to determine the susceptibility of the 
gastrointestinal tract to colonization of E. coli O157. The goal of this study was to 
determine whether dexamethasone immunosuppression plays a role in the level and 
duration of fecal shedding of E. coli O157.  
Materials and Methods 
The basic outline of the study is illustrated in Figure 2.1. 
Calf Management  
Twelve two-day-old Holstein bull calves were obtained from a dairy and transported to a 
BL-2 facility at Kansas State University. Upon arrival, each calf was ear tagged and 
placed in a separate pen. One calf was euthanized one day after arrival due to poor and 
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declining health. Calves were randomly assigned to either the dexamethasone treatment 
or the control group and arranged in the BL-2 facility by placing all dexamethasone 
treated calves (n=6) in one room of the barn and all controls (n=5) in a separate room of 
the barn. Each calf was housed in an individual pen with individual feed and water 
buckets and contact between calves was not allowed. All calves were offered free choice 
water from day 1. Calves were initially bottle fed milk replacer without antibiotics, and 
within the first week, they were transitioned into drinking milk replacer from a bucket. 
Three weeks after their arrival, all calves were offered grain and free choice hay.  
Pre-Challenge 
Calves were acclimated to the facility for one week and fecal samples were 
obtained from the rectum once and tested for E. coli O157 to establish negative status 
according to the standard protocol in our lab (Alali et al., 2004). Briefly, a one gram fecal 
sample was incubated (37oC) for six hours in nine mL of gram negative broth (BD, 
Franklin Lakes, NJ) with vancomycin (8g/L), cefixime(0.05mg/L), and cefsulodin 
(10mg/L) (GN-vcc). The samples underwent manual immunomagnetic separation using 
the standard protocol, and were plated on Sorbitol MacConkey agar containing cefexime 
(50 ng/ml) and tellurite (2.5 g/ml) (SMAC-ct) and incubated overnight at 37 oC. A 
maximum of six colonies morphologically typical of E. coli O157 were selected, streaked 
on blood agar and incubated overnight. Indole and latex agglutination tests were 
performed, and those colonies that were positive on both tests were confirmed as E.coli 
with Rapid API kits (Biomerieux, Hazelwood, MO Three days prior to inoculation with 
E. coli O157, jugular vein blood samples were taken from each calf into heparinized 
blood tubes and CBCs were run to obtain baseline blood-work values.  
Calf Challenge and Sampling Schedule 
After acclimatization, all calves were inoculated with 109 CFU of nalidixic acid 
resistant E. coli O157 directly into the rumen using an esophageal feeding tube. The 
inoculum was prepared from a frozen stock of three strains (01-2-10004, 01-2-10567, and 
01-2-10597) adapted to nalidixic acid (20 µg/ml). Each strain was grown individually, 
pooled together on the day of inoculation, and added to milk replacer to inoculate the 
calves. Treatment calves received dexamethasone (0.25mg/kg, IM) for two days before, 
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the day of, and two days after oral inoculation with the O157. Control calves did not 
receive dexamethasone injections. All calves were examined daily and fecal samples 
were collected three times a week (Monday, Wednesday, and Friday) for detection and 
enumeration of the nalidixic resistant strain of E. coli O157. Blood samples were 
collected from all calves into EDTA tubes and CBCs were run on days three, 14, 25, and 
42 post E. coli O157 inoculation. Fifty-one days post- E. coli O157- inoculation (21 days 
after the last calf stopped shedding  E. coli O157) all calves were necropsied and samples 
from the gastrointestinal tract (lingual tonsil swab, cranial lymph node swab, rumen 
contents, omasal contents, abomasal contents, jejunal contents, ileum contents, cecal 
contents, colon contents, rectal contents, recto-anal junction mucosal swab, mesenteric 
lymph node swab, peyers patches swab, gallbladder swab, rectum tissue, gallbladder 
tissue) were taken for the detection of the nalidixic resistant strain of E. coli O157.  
Detection and Enumeration of E. coli O157 Pre-necropsy 
Fecal samples were collected on the mornings of sampling days and within one 
hour a one gram sample from each calf was placed into nine mL of GN-vcc broth and 
vortexed. For enumeration, 10-1 to 10-4 serial dilutions of fecal suspensions were made 
in peptone water dilution banks, and 0.1mL of each of the dilutions were spread plated, in 
triplicate, onto SMAC containing 20 µg/mL naladixic acid (SMAC-nal). Plates were 
incubated overnight and sorbitol negative colonies were counted and recorded. A 
maximum of three colonies were plated on blood agar, incubated overnight, and indole 
and latex agglutination tests performed to ensure that colonies were E. coli O157. 
Two additional methods were used to detect calves shedding below the detection 
limit (<102) of the direct enumeration. The remaining GN-vcc broth and sample was 
processed according to our standard lab protocol of IMS following a six hour incubation. 
Colonies that were indole and agglutination positive following the standard protocol, 
were plated onto SMAC-nal and incubated overnight to confirm the nalidixic acid 
resistance of the E. coli O157 being shed. Additionally, a selective enrichment technique 
was also done to detect E. coli O157:H7 if the enumeration plating did not provide 
positive results. A one mL aliquot of the six hour incubated sample in GN-vcc was 
transferred into a new tube containing nine mL GN-vcc broth and incubated overnight. If 
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no sorbitol negative colonies were detected on the direct enumeration platings, 0.1mL 
from this enriched sample was spread plated onto SMAC-ct-nal and incubated overnight 
at 37°C. From these plates a maximum of three sorbitol negative colonies were picked, 
plated on blood agar, and incubated overnight. These colonies were then indole and latex 
agglutination tested to confirm they were E. coli O157.  
Measurement of phagocytic and oxidative burst activities of bovine leukocytes 
Blood samples were collected in heparin tubes via jugular venipuncture on days 
one, 12, and 40 post-final-dexamethasone administration and processed within one hour 
of collection. Samples were processed and then analyzed using a FACScan flow 
cytometer (Becton Dickinson, San Jose, CA, USA) as described by Flaminio et al (2002).  
Detection and Enumeration of E. coli O157 Post-necropsy 
Gastrointestinal content samples (rumen, omasum, abomasum, jejunum, ileum, 
and rectum) were processed according to our standard lab protocol as described above 
with one gram of contents being used.  Tissue swabs (tonsil, cranial lymph node, gall 
bladder, mesenteric lymph node, peyer’s patches, and recto-anal mucosal swab) were 
placed in three mL GN-vcc broth and processed by the procedure used for fecal samples.  
Tissue samples (gall bladder and recto-anal mucosa) were cut into approximately one 
gram pieces, suspended in GN broth, and homogenized for one minute with a tissue 
homogenizer (Brinkman Instruments, Westbury, NY). The suspension was then 
processed as described previously. 
Statistical Analysis 
Data analysis was performed using SAS. A repeated measures analysis of 
variance with calf nested within group was performed using the log-transformed counts 
of E. coli O157 shedding for each day as the dependant variable. Individual calf, calves 
as a group, days post-inoculation, and group by day were repeated. Two data sets were 
run: the first including shedding values from all days of the study and the second 
including only days two to 11 post-inoculation. T-tests were performed using calf nested 
within group and the percent phagocytosis or the percent phagocytosis with oxidative 
burst as the dependent variable.  
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Results 
All calves tested negative for E. coli O157 in feces prior to oral inoculation. The 
CBC results (Tables 2.1-2.3) from the dexamethasone treated group from day three post-
inoculation showed a marked neutrophilia and a lymphopenia compared to the control 
group, suggesting that dexamethasone induced immunosuppression was achieved.  The 
CBC results from day 14 post-inoculation showed a resolution in the neutrophilia and the 
presence of a slight lymphopenia in the dexamethasone treated group. Both the 
neutrophilia and lymphopenia were resolved in subsequent blood samples (days 25 and 
42). There were no statistical differences in phagocytosis and oxidative burst activities 
between the control and dexamethasone treated groups (data shown in Table 2.4).  
The peak shedding level of E. coli O157 by all calves was four days post-
inoculation, after which there was a sharp decline in the fecal concentration (Figure 2.2). 
Individual calves shed at variable levels from day seven post-inoculation until the end of 
the study. Starting on week two post-inoculation there were animals that were detected as 
shedding via only enrichment methods. All calves stopped shedding E. coli O157 in their 
feces by four weeks post-inoculation.  Analysis indicated a day by treatment group 
interaction over the course of the study. Analysis using intervals of days showed that on 
days four and seven post-inoculation, the dexamethasone treated group of calves shed E. 
coli O157 at a higher level (p=0.038) than the control group. Thereafter, both the 
dexamethasone treated and control groups shed at approximately the same levels and for 
the same length of time. All samples collected at necropsy were negative for E. coli O157 
(no data shown). All calves were healthy throughout the length of the study. 
Discussion 
Several studies have used oral inoculation of calves with E. coli O157 to detect 
duration and level of shedding of the bacteria in feces (Brown, et al., 1997; Cray and 
Moon, 1995; Sanderson, et al., 1999). As in those studies, none of the calves in this study 
became clinically ill. The duration of shedding observed in this study is consistent with 
Cray and Moon’s (1995) and Sanderson’s (1999) findings with orally inoculated calves 
as well as with cattle in the field (Besser et al, 1997).  
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While there have been studies examining the effects of weather, feeding 
strategies, and strategies of inoculation to examine duration and magnitude of E. coli 
O157 fecal shedding (Dunn et al, 2004;Cray et al, 1998; Shere et al, 2002), this is the first 
study to examine the effect immunosuppression has on fecal shedding of E. coli O157.  
High doses of dexamethasone are commonly used for stress-like immunosuppression in 
cattle (Anderson et al, 1999) and usage has been associated with reoccurrence of latent 
infectious bovine rhinotracheatis virus and bovine herpesvirus 2, as well as some blood 
born parasitic diseases (Roth and Kaeberle, 1982). Clinically, cattle treated with 
dexamethasone show a decrease in the number of circulating lymphocytes and a dramatic 
rise in the neutrophil numbers (Anderson, et al., 1999; Burton, et al., 1995; Roth and 
Kaeberle, 1982). Accompanying the lymphopenia, Anderson et al (1999) have found that 
IgM concentrations are decreased with dexamethasone injection. The neutrophilia that 
results from dexamethasone injections is due to the neutrophils’ reduced ability to attach 
to the vascular endothelium and migrate into the tissues to ingest bacteria (Burton et al, 
1995). Furthermore, Roth and Kaeberle (1981) found that the neutrophils ability to 
phagocytose and undergo oxidative metabolism to destroy bacteria are impaired but 
returned to normal 48 hours post-dexamethasone injection. The calves in this study that 
received the dexamethasone injection responded with lymphopenia and neutrophilia as 
adult cattle have in past studies (Anderson, et al., 1999; Roth and Kaeberle, 1981). 
However, there were no differences in the phagocytosis-oxidation abilities of the 
neutrophils between the dexamethasone treated and control groups. This may in part be 
due to the differences in the dosage of dexamethasone given (0.04 mg/kg versus a 
0.08mg/kg followed by a 0.25mg/kg doses in those studies). Also, lack of effect may be 
because neonatal calves were used in our study, whereas Roth and Kaeberle used adult 
cattle (1981). Studies have shown that dexamethasone’s affects last anywhere from two 
to 12 days post injection (Anderson, et al., 1999; Burton et al, 1995). Since five high end 
dosages of 0.25mg/kg were given to the calves in this study, a longer duration of 
immunosuppression was expected. Our CBC data suggest that the calves were 
immunosuppressed on day three but not on day 14 post-E. coli O157 inoculation. 
Because no blood samples were taken during this interval, the duration of 
immunosuppression could not be ascertained. 
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Data from this study suggest that there may be a relationship between 
immunosuppression and level of E. coli O157 shedding. Dexamethasone-treated calves 
shed at higher levels during the days when they would have been immunosuppressed, 
suggesting there may be a time dependent correlation between dexamethasone 
immunosuppresion and the concentration of E. coli O157 an animal will shed.  It could 
be surmised that a higher level of E. coli O157 will be shed for as long as dexamethasone 
suppresses the immune system. If this is true, level or duration of shedding could be 
impacted by persistent immunosuppression in cattle.  
Calves in this study were necropsied four weeks after the last calf stopped 
shedding E. coli O157 in the feces. Stoffregen et al (2004) cultured O157 in gallbladders 
after dexamethasone injection of calves but necropsies were performed four days post-E. 
coli O157 inoculation. Our study provides no support for a site of persistent colonization 
in the gastrointestinal tract of E. coli O157, which is in agreement with a recent report by 
Reinstein et al. (2007). 
The dexamethasone model used in this study may be comparable to short term 
immunosuppression caused by stresses common in the cattle industry such as weaning 
(dietary changes), confinement, and transport. In all cases there is an increase in cortisol 
levels, although there are not necessarily the same blood cell effects with environmental 
stressors as there are with dexamethasone injections. While Barham et al (2002) found 
that shipping steers and heifers on trailers for 30-40minutes caused an increase in the 
fecal shedding of Salmonella spp, there was no increase in E. coli O157 shedding. 
However, Bach et al (2004) found that non-preconditioned steer calves that were hauled 
for 15 hours did have a significantly higher level of E. coli O157 shedding. Another study 
showed that calves that had feed withheld for 48 hours prior to inoculation with E. coli 
O157 were more likely to become infected and also shed higher levels of E. coli O157 in 
their feces (Cray et al, 1998).  
Conclusion 
In summary, the data from this study suggest that short-term immunosuppressed 
cattle may shed E. coli O157 at higher levels in their feces, and thus be a significant 
source of exposure in the farm or feedlot. This environmental fecal contamination could 
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lead to increased levels of transmission between cattle in the same environment. Once the 
cattle that are potentially shedding E. coli O157 are transported, they have the possibility 
of inoculating new environments and cattle. Another perspective to consider is how long 
term immunosuppression, such as persistent infection with Bovine Viral Diarrhea virus, 
would potentially effect the long term fecal shedding of E. coli O157. Further research is 
needed to define the range of immunosuppressive sources and their effects on fecal 
shedding of E. coli O157 in cattle.  
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Table 2.1: Selected CBC results from pre-O157 inoculation and pre-dexamethasone 
injection.            
Calf # Segmented 
neutrophils/μL
Band 
neutrophils/μL
Lymphocytes/μL 
Group 1  Dexamethasone   
1 3600 0 2800 
2 1200 0 3600 
3 3600 0 2600 
5 4500 0 4100 
6 4600 0 1600 
10 4600 0 4900 
Group 2  Control   
4 4300 0 1900 
7 2600 0 1800 
8 1700 0 2300 
9 1100 0 5800 
11 1600 0 2100 
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Table 2.2: Selected CBC results from day three post-O157 inoculation.  
Calf # Segmented 
neutrophils/μL
Band 
neutrophils/μL
Lymphocytes/μL 
Group 1  Dexamethasone   
1 18000 0 980 
2 14000 0 1300 
3 20000 0 870 
5 13000 160 2600 
6 11000 400 1900 
10 22000 0 980 
Group 2  Control   
4 2500 0 2200 
7 1100 0 3000 
8 5500 0 2300 
9 720 330 3300 
11 1900 0 1600 
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Table 2.3: Selected CBC results from day 14 post-O157 inoculation. 
Calf # Segmented 
neutrophils/μL
Band 
neutrophils/μL
Lymphocytes/μL 
Group 1  Dexamethasone   
1 3000 0 1100 
2 1900 0 1300 
3 2300 0 1100 
5 1100 0 2700 
6 4700 0 2400 
10 2400 0 1300 
Group 2  Control   
4 1700 0 2400 
7 3200 0 2100 
8 3600 0 2400 
9 12000 170 4400 
11 760 0 2300 
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Table 2.4. Phagocytosis only and phagocytosis with oxidative burst results (average + 
standard error).  
% Phagocytosis Day 3 post-O157 inoculation Day 14 post-O157 inoculation 
Control Group 25.44 + 3.99 51.56 + 3.99 
Dexamethasone Group 38.46 + 3.64 43.30 + 3.64 
   
% Phagocytosis with 
Oxidative Burst 
Day 3 post-O157 inoculation Day 14 post-O157 inoculation 
Control Group 19.23 + 6.98 15.27 + 6.98 
Dexamethasone Group 26.55 + 6.37 22.68 + 6.37 
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 Birth -7 0              7             14           28           35            42            49          56 
  
Days 
Arrival of 
calves to BL-2 
facility.  
Calves euthanized. 
Necropsy samples 
cultured.  
 = Blood counts 
= Pre-challenge fecal 
sample. Thereafter, 3 
fecal samples were taken 
weekly.     
= Dexamethasone 
injections given daily on 
days -2 to 2 to 
dexamethasone group.  
= E. coli challenge on day 0 
to dexamethasone treated 
and control groups.  
Figure 2.1: Timeline of project details.  
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Figure 2: Log10 average fecal shedding of E. coli O157:H7 from dexamethasone treated 
and control calves.  
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 CHAPTER 3 - Impact of Persistent Bovine Viral Diarrhea 
Viral Infection on the Duration and Level of Shedding of E. 
coli O157:H7 in Calves 
 
Abstract 
The goal of this study was to determine whether calves immunosuppressed by 
persistent infection with bovine viral diarrhea virus (BVDV) will shed Escherichia coli 
O157 at a higher level and for a longer duration than a normal animal. Bovine viral 
diarrhea is an economically important viral disease in cattle. BVDV causes 
immunosuppression in the animal, which often leads to secondary infection with other 
pathogens resulting in severe illness. Nine calves, six to eight week old, persistently 
infected with non-cytopathic BVDV and eight normal calves obtained from separate 
cow-calf operations were used in the study. BVDV status, positive or negative, of all 
calves was confirmed by repeated testing throughout the study. Both groups were orally 
inoculated with 109 CFU of five nalidixic-acid resistant strains of E. coli O157. All 
calves were examined daily and fecal samples were collected three times a week for 55 
days for detection and enumeration of the nalidixic-acid resistant E. coli O157. Calves 
were then necropsied and samples from the gastrointestinal tract were taken for the 
detection of the nalidixic-acid resistant E. coli O157. Data analysis indicated no statistical 
difference in the concentration of E. coli O157 shed or the duration of shedding between 
the persistently infected BVDV calves and the control calves throughout the length of the 
study. Our data suggest that immunosuppression caused by persistent infection with non-
cytopathic BVDV infection does not play a role in the level or duration of shedding of E. 
coli O157:H7 in cattle.  
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Introduction 
Enterohemorrhagic Escherichia coli O157:H7 has emerged as a significant food-
borne pathogen over the past two decades. Infected cattle are asymptomatic shedders of 
the bacteria, but human infection can cause hemorrhagic colitis; which can be more 
severe in children, the elderly, and other immunocompromised individuals. In the United 
States, 85-95 percent of severe hemolytic-uremic syndrome in children is caused by E. 
coli O157:H7 (Armstrong, et al., 1996). Studies have indicated that E. coli O157 is a 
ubiquitous agent within cattle populations. Beef and beef products have been a significant 
human source for the pathogen (Hancock, et al, 1998; Galland, et al 2001). However, 
more recently, fresh vegetables, possibly contaminated with cattle feces, have become the 
primary source of human infection (MMWR, 2007).   
Some researchers suggest that a few animals in a herd may shed E. coli O157 at 
higher levels and for a longer duration of time compared to other animals in the same 
herd. These animals have been termed “super shedders.” (Omisakin et al., 2003).  These 
animals may be important in the on-farm epidemiology, ecology, and shedding of E. coli 
O157 and may also play an important role in pre-harvest food safety. According to 
modeling data (Matthews, et al., 2006), a small number of “super shedders” may be 
responsible for the majority of transmission within a farm and thus result in an elevated 
farm prevalence. Therefore, determining what causes these “super shedders” to shed at 
higher levels and/or for a longer duration is important.  
Bovine viral diarrhea virus (BVDV) is ubiquitous in the cattle population in the 
U. S. and is known to be immunosuppressive. Cattle may be transiently or persistently 
infected with BVDV.  It has been well documented that BVDV is immunosuppressive in 
various clinical forms of BVD (Chase, et al., 2004).  The objective of this study was to 
determine whether immunosuppression caused by BVDV, plays a role in the level and 
duration of fecal shedding of E. coli O157.  
 
Materials and Methods 
Figure 3.1 provides a basic time sequence of the study. 
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Calf Management 
Eight 6-8 week old BVD negative calves from a single cow-calf operation and 
nine immunohistochemistry (IHC) positive BVD calves from two different cow-calf 
operations were obtained and transported to a BL-2 facility at Kansas State University. 
BVD negative calves and BVD positive calves were transported separately and were 
maintained separately throughout the study. Upon arrival to the BL-2 facility, calves were 
placed into pens in groups; the controls were randomly separated into two pens, and the 
BVD calves were placed in two pens according to the source they were from. After one 
week, each calf was housed in an individual pen with individual feed and water buckets 
and physical contact between calves was prevented. All calves were offered free choice 
water from day one. Calves were weaned upon arrival and within a week, all calves were 
consuming grain (dairy calf grower diet from the local cooperative), two flakes alfalfa 
hay, and free choice grass hay everyday.   
Pre-Challenge 
Calves were acclimated to the facility for 10 days during which three fecal 
samples were obtained from the rectum and tested for E. coli O157 (Sanderson et al., 
2006) . Briefly a one gram fecal sample was incubated in nine mL of gram negative broth 
(BD, Franklin Lakes, NJ) with vancomycin (8 g/L), cefixime(0.05 mg/L), and cefsulodin 
(10 mg/L) (GN-vcc) at 37oC for six hours. The samples underwent manual 
immunomagnetic separation (IMS), and were plated on Sorbitol MacConkey agar 
(Becton Dickinson, Franklin, MD) containing cefixime (50 ng/ml) and tellurite (2.5 
g/ml) (SMAC-ct) and incubated overnight at 37 oC. Up to six colonies that were 
morphologically typical of E. coli O157 were streaked on blood agar and incubated 
overnight. Colonies that were positive on both indole and latex agglutination tests (Oxoid 
Ltd., Basingstoke, U.K.) were confirmed as E.coli with Rapid API kits (Biomerieux, 
Hazelwood, MO). Two days prior to inoculation with E. coli O157, jugular vein blood 
samples were taken from each calf into heparinized blood tubes to provide baseline 
values for leukocyte activity.  
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Assessment of BVDV status 
The BVD-PI calves were identified in the herds of origin by positive 
immunohistochemistry testing and then confirmed as persistently infected by virus 
isolation or a second immunohistochemistry test, with all tests being conducted prior to 
arrival to the Kansas State University facility.  Upon arrival at the Kansas State 
University BL-2 facility, ear notches were obtained on all the control calves for a BVD 
immunohistochemistry test and jugular blood samples were taken from all calves for 
virus isolation. During the course of the study, three additional virus isolations were 
performed on days 5-6, 19-20, and 33-34 post-E. coli O157 inoculation, (control calves 
were sampled the first day and PI calves were sampled the second day) to confirm the 
negative BVD status of the control calves, and persistent status of the BVD calves.  
Calf Challenge and Sampling Schedule 
All calves were inoculated with 109 colony-forming units of E. coli O157 using 
an esophageal feeding tube. The inoculum was prepared from a frozen stock of five 
strains adapted to nalidixic acid (20 µg/ml) (01-2-10004, 01-2-12329, 01-2-10530, 01-2-
10561, and 01-2-8970). Each strain was grown individually, pooled together on the day 
of inoculation, and diluted with water to inoculate the calves. Calves were examined 
daily and fecal samples were collected three times a week (Monday, Wednesday, and 
Friday) for detection and enumeration of the nalidixic acid resistant E. coli O157. Blood 
samples from the jugular vein were collected from all calves into heparinized and regular 
blood tubes on days 5-6, 19-20, 33-34, and 54-55 post-E. coli O157 inoculation: PI calves 
were sampled the first day and control calves were sampled the second day. Eight weeks 
post- E. coli O157 inoculation, nine calves (five BVD-PIs and four controls) were 
euthanized with Fatal-Plus® and necropsied. The remaining eight calves (four BVD-PIs 
and four controls) were euthanized and necropsied four days afterwards.  
Detection and Enumeration of E. coli O157 Pre-necropsy 
Fecal samples were collected on the morning of the sampling days and a one gram 
sample from each calf was placed into nine mL of GN-vcc broth within one hour of 
collection and the tubes were vortexed. Samples were enumerated by making 10-1 to 10-
4 serial dilutions of fecal suspensions in peptone water dilution banks, and 0.1mL of each 
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of the dilutions were spread plated, in triplicate, onto SMAC containing 20 µg/mL 
naladixic acid (SMAC-nal). Morphologically typical, sorbitol negative colonies on 
enumeration plates were counted and recorded after overnight incubation. A maximum of 
three colonies were plated on blood agar, incubated overnight, and indole and latex 
agglutination tests performed to ensure that colonies were E. coli O157. 
Two additional methods were used to detect calves shedding below the detection 
limit (<102) of the direct enumeration. First, the remaining sample in the GN-vcc broth 
was incubated for six hours at 37°C and then underwent IMS. Resulting colonies that 
were indole and agglutination positive were plated onto SMAC-nal and incubated 
overnight to confirm the nalidixic acid resistance. Secondly, a selective enrichment 
technique was done to detect E. coli O157 if the enumeration plating did not provide 
positive results. For this, a one mL aliquot of the six hour incubated sample in GN-vcc 
was transferred into a new tube containing nine mL GN-vcc broth and again incubated 
overnight at 37°C.  If no sorbitol negative colonies were detected on the direct 
enumeration platings, a 0.1mL aliquot from this enriched sample was spread plated onto 
SMAC-ct-nal and incubated overnight at 37°C. From these plates a maximum of three 
sorbitol negative colonies were picked, plated on blood agar, and incubated overnight. 
These colonies were then indole and latex agglutination tested to confirm they were E. 
coli O157.  
Measurement of phagocytic and oxidative burst activities of bovine leukocytes 
and Immunophenotyping 
Blood samples were collected in heparin tubes via jugular venipuncture on days 
2-3 prior to E. coli O157 inoculation and on days 19-20 and 33-34 post-E. coli O157 
inoculation (controls sampled the first day and PIs sampled the second day) and 
processed within one hour of collection. Phagocytic and oxidative burst activities were 
analyzed in a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) as 
described by Flaminio et al (2002). Immunophenotyping of leukocytes was done using 
monocolonal antibodies (VMRD, Pullman, WA, USA) specific for CD2, CD4, CD18, 
CD14, CD21, CD44, CD62L, MHC I, MHC II, and TCR. Briefly, whole blood samples 
were centrifuged at 3400rpm for six minutes. The plasma layer was aspirated and 
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discarded. Ammonium chloride was added to the remaining pellet and allowed to sit for 
five to ten minutes to allow the erythrocytes to lyse. Samples were then centrifuged at 
3400rpm for three minutes and the supernatant was discarded. The leukocyte pellet was 
then washed with 0.1M PBS, centrifuged at 3400rpm for three minutes, the supernatant 
was discarded, and the pellet was re-suspended in PBS to obtain a leukocyte 
concentration of 1x107 cells/mL. A 100µL aliquot of cells and 100µL of the appropriate 
monoclonal antibody were mixed and incubated for twenty minutes in the dark at two to 
six degrees Celsius. The samples were then washed in three mL of PBS, centrifuged on 
high for three minutes, and the supernatant was discarded. A 100µL aliquot of the 
fluorescent conjugated secondary antibody was added, mixed, and the samples were 
placed in the dark for ten minutes at two to six degrees Celsius. The samples were 
washed in three mL of PBS, centrifuged at high speed for three minutes, and the 
supernatant was discarded. The cell pellet was re-suspended with 250mL of PBS and the 
samples were analyzed using the FASCcan flow cytometer.  
Detection and Enumeration of E. coli O157 in Samples Collected at Necropsy 
At necropsy, one gram samples of gastrointestinal content from the rumen, 
omasum, abomasum, jejunum, ileum, and rectum were processed according to our 
standard lab protocol as described above.  Tissue swabs from the tonsil, cranial lymph 
node, gall bladder, mesenteric lymph node, peyers patches, and recto-anal mucosa were 
placed in three ml GN-vcc broth and then processed by the same procedure used for 
previously descrived fecal samples.  Tissue samples (gall bladder and recto-anal mucosa) 
were cut into approximately one gram pieces, suspended in nine mL GN-vcc broth, and 
homogenized for one minute with a tissue homogenizer (Brinkman Instruments, 
Westbury, NY). The suspension was then processed as described previously. 
Statistical Analysis 
Using a commercially available statistical software (SAS version 8.0, Cary, NC), 
a repeated measures analysis of variance with calf nested within group was performed on 
the log of the enumerated counts of E. coli O157 fecal shedding for each day. Individual 
calf, group, day post-inoculation, and group by day were the repeated measures. 
Phagocytic and oxidative burst activity and immunophenotyping data was also evaluated 
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using a repeated measures analysis of variance with calf nested within group. Individual 
calf, group, day pre- or post-inoculation, and group by day were repeated measures. Due 
to the small number of samples, a p-value less than or equal to 0.0047 was designated for 
significance using the Bonferroni correction (0.05/12 antigens = 0.0047).   
 
Results 
All calves were healthy throughout the length of the study. All control calves 
were negative for BVDV by IHC and virus isolation at all sampling times throughout the 
study and all BVD-PI calves remained virus isolation positive at all sampling times. Two 
control calves tested positive for E. coli O157 in the first pre-challenge fecal collection 
but tested negative on days seven and two prior to inoculation. All other calves tested 
negative for E. coli O157 in feces prior to oral inoculation. The peak shedding level of E. 
coli O157 by all calves was one day post-inoculation, after which there was a sharp 
decline in the fecal concentration (Figure 3.2). Individual calves shed at variable levels 
throughout the study. Overall both the control and BVD groups shed at approximately the 
same levels and for the same length of time, indicating no significant difference in 
shedding levels between the two groups.  One and a half weeks post-inoculation there 
were animals that were culture positive only via enrichment methods. Nine calves (four 
controls and five PIs) had negative fecal samples for at least ten days prior to necropsy. 
Six calves (three controls and three PIs) were still detected as shedding E. coli O157 in 
their feces three days prior to necropsy. Of these six calves, only the three control calves 
tested positive for E. coli O157 at necropsy. The positive samples were collected from the 
cecal, colon, and rectal contents, and rectal tissue. The phagocytosis, oxidative burst, and 
immunophenotyping analysis showed no difference between the leukocyte activities of 
the BVD-PI calves and the control calves (Tables 3.1-3.6).   
 
Discussion 
Even though nine of the calves in this study were persistently infected with 
BVDV, none of the calves became clinically ill during the course of the study. This is 
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consistent with previous studies that have used oral inoculation of calves with E. coli 
O157 to detect duration and level of shedding of the organism in feces (Brown, et al., 
1997; Cray and Moon, 1995; Sanderson, et al., 1999). The duration of shedding observed 
in this study is consistent with data from both Cray and Moon (1995) and Sanderson et al 
(1999) in orally inoculated calves as well as with cattle in the field (Besser et al, 1997).  
Causes of immunosuppression in cattle include stress, such as weaning (dietary 
changes), confinement, and transport. In all cases there is an increase in cortisol levels, 
which may alter leukocyte counts in the animal. Barham et al (2002) found that short 
term shipping of steers and heifers on trailers (30-40minutes) caused an increase in the 
fecal shedding of Salmonella spp, but no increase in E. coli O157 fecal shedding. Bach et 
al (2004) studied stress in relation to fecal shedding of E. coli O157 in four groups of 
calves: the first and second groups were pre-conditioned (vaccinated and weaned at four 
or two weeks prior to transport) prior to either a three or 15 hour transport to the feedlot, 
and the third and fourth groups (non-preconditioned) were weaned one day prior to either 
a three or 15 hour transport and were vaccinated after they arrived at the feedlot. Of all 
four groups, only the non-preconditioned steer calves hauled for 15 hours shed E. coli 
O157 had a significantly higher fecal prevalence. This study suggested that dividing the 
pre-harvest stresses over a period of time, rather than compounding them at one time, 
may reduce shedding levels of E. coli O157. Finally, Cray et al (1998) showed that calves 
that had feed withheld for 48 hours prior to inoculation with E. coli O157 were more 
likely to become infected and also shed higher levels of E. coli O157 in their feces. As a 
whole, these studies suggest that stress events may change the prevalence and possibly 
the shedding dynamics of E. coli O157. However, whether these changes were due to 
general effects on microbial ecology of the gut or the effect of immunosuppression is 
unknown.  
There have been studies examining the effects of weather, feeding strategies, and 
strategies of inoculation to examine duration and magnitude of E. coli O157 fecal 
shedding (Dunn et al, 2004; Cray et al, 1998; Shere et al, 2002); however, this is the first 
study to examine the effect of BVDV persistent infection may have on fecal shedding of 
E. coli O157.  If a cow is infected with a noncytopathic BVD virus between days 45 and 
125 of gestation, the virus may infect the fetus and result in the birth of a calf persistently 
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infected (PI) with the noncytopathic BVD virus (Baker, 1995). These cattle in turn shed 
large numbers of the virus into their environment and are therefore a significant threat to 
spread of the virus to naïve cattle (Houe, 1999). Persistently infected cattle may have 
decreased weight gain and decreased growth, but may also appear clinically normal. 
Additionally, data indicate that PI cattle have decreased neutrophil and lymphocyte 
functions (Brown, et al, 1991 and Chase, et al, 2004). In healthy calves inoculated with a 
non-cytopathic strain of BVD, Ellis et al (1988) also found a decrease in the number of 
circulating B and T lymphocytes. Cattle with BVDV immunosuppression often succumb 
to secondary bacterial respiratory infections causing substantial economic loss 
(Campbell, 2004). Brewoo et al (2007) found that there was no difference in the 
phagocytic activities and leukocyte profiles between persistently infected adult BVD 
cattle and controls. According to our CBC and flow cytometric data, there was no 
significant difference in leukocyte numbers, phagocytic or oxidative burst activity, or 
expression of antigens on leukocytes between BVD-PI calves and control calves, which 
is in agreement with the Brewoo paper. 
Our data does not support a role for BVD-PI infection in increasing either the 
level or duration of shedding of E. coli O157 in cattle. However, other alternative effects 
may exist. BVDV also causes transient infections in cattle, which are more common than 
persistent infections. Data shows that healthy calves experimentally infected with a field 
isolate of BVD had a significant decrease in the number of neutrophils, lymphocytes, and 
monocytes 3-5 days post inoculation compared to control calves (Archambault, et al, 
2000). Another study showed that calves inoculated with a non-cytopathic strain of 
BVDV had a significant decrease in the number of circulating platelets (Bezek, et al, 
1994). While it has been documented that PI cattle are immunosuprressed (Potgieter, 
1995), the mechanism causing the immunusuppression in poorly understood. More 
research needs to be done to determine the difference in the immunosuppressive factors 
between acutely infected and persistently infected BVD cattle.  
Nine calves in this study were necropsied eleven days after the last calf stopped 
shedding E. coli O157 in the feces. Of the remaining eight calves, six were still shedding 
E. coli O157 three days prior to necropsy. Of those six, only three had O157 cultured 
from the necropsy samples. These positive sites included cecal, colon, and rectal 
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contents, and homogenized rectal tissue.  Stoffregen et al (2004) cultured O157 in 
gallbladders of calves given dexamethasone injections and necropsied four days after E. 
coli O157 inoculation. Our study provides no support for a site of persistent colonization 
of E. coli O157 in the gallbladder, which is in agreement with a recent report by 
Reinstein et al. (2007).   
Conclusion 
In summary, the data from this study do not confirm that calves persistently 
infected with BVDV alter the duration or level of fecal shedding of E. coli O157. 
However, further research is needed to define the range of immunosuppressive factors 
and their effects in viral inection on fecal shedding of E. coli O157 in cattle.  
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Table 3.1. Results of percent phagocytosis only and percent phagocytosis with oxidative 
burst (average + standard error). Days are in reference to E. coli O157 inoculation 
(controls sampled the first day and BVD-PIs sampled the second day).  
% Phagocytosis Days -3 and -2 Days 19 and 20 Days 33 and 34 
Control Group 33.72 + 4.56 25.43 + 4.56 30.60 + 4.56 
BVD-PI Group 36.74 + 4.30 21.76 + 4.30 18.03 + 4.30 
% Phag-Ox    
Control Group 25.45 + 3.55 30.71 + 3.55 44.40 +3.55 
BVD-PI Group 22.89 + 3.35 36.51 + 3.35 38.06 + 3.35 
 
 
Table 3.2. P-values for Phagocytosis and oxidative burst data. (p < 0.0047 is significant) 
 Whole data set Days -3and-2 Days 19and20 Days 33and34
%Phagocytosis 0.27 0.63 0.21 0.05 
% Phag-Ox 0.59 0.60 0.24 0.41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.3. Percentage of calves’ lymphocytic cells (+ standard error with 95% CI) reacting with monoclonal antibody specific to 
antigens tested. (Days are in reference to day of E. coli O157 inoculation with controls sampled first day and BVD PIs sampled second 
day. 
Antigen Group Day -3and-2 Day 19and20 Day 33and34
CD 2 Control 25.13+3.19 34.44+3.19 42.02+3.19 
 PIBVD 28.62+3.01 38.11+3.01 38.64+3.01 
CD4 Control 7.81+2.19 17.23+2.19 20.85+2.19 
 PIBVD 9.97+2.07 23.23+2.07 22.53+2.07 
CD8 Control 12.43+1.96 11.74+1.96 24.44+1.96 
 PIBVD 13.63+1.85 14.38+1.85 18.93+1.85 
CD11a Control 33.02+4.20 1.95+4.20 28.77+4.20 
 PIBVD 22.05+3.96 4.54+3.96 24.26+3.96 
CD14 Control 14.22+2.71 5.23+2.71 15.87+2.71 
 PIBVD 10.28+2.55 7.99+2.55 18.75+2.55 
CD21 Control 2.47+4.35 1.14+4.35 9.36+4.35 
 PIBVD 3.23+4.10 13.25+4.10 6.74+4.10 
CD44 Control 52.38+4.12 56.13+4.12 73.28+4.12 
 PIBVD 40.90+3.89 58.51+3.89 67.83+3.89 
 
 
 
 
 
 
 
Antigen Group Day -3and-2 Day 19and20 Day 33and34
CD62L Control 47.58+2.70 69.97+2.70 71.64+2.70 
 PIBVD 45.15+2.55 63.79+2.55 68.47+2.55 
MHCI Control 89.40+3.48 98.33+3.48 99.16+3.48 
 PIBVD 96.49+3.28 90.47+3.28 98.05+3.28 
MHCII Control 46.68+4.68 18.21+4.68 48.99+4.68 
 PIBVD 60.00+4.41 29.33+4.41 33.25+4.41 
TCR Control 8.28+2.47 31.3+2.47 33.67+2.47 
 PIBVD 8.56+2.47 22.56+2.47 25.73+2.47 
IL2R Control 6.31+3.50 1.92+3.50 12.38+3.50 
 PIBVD 5.14+3.29 10.83+3.29 9.54+3.29 
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Table 3.4. P-values for percentages given in Table 3.3. (Days are in reference to day of 
E. coli O157 inoculation) p < 0.0047 is significant.  
Antigen Whole data set Day -2and-3 Day 19and20 Day 33and34 
CD2 0.72 0.43 0.41 0.47 
CD4 0.17 0.48 0.05 0.58 
CD8 0.76 0.66 0.33 0.05 
CD11a 0.20 0.06 0.66 0.44 
CD14 0.80 0.30 0.48 0.44 
CD21 0.44 0.89 0.05 0.66 
CD44 0.24 0.05 0.68 0.34 
CD62L 0.06 0.02 0.10 0.40 
MHCI 0.82 0.15 0.11 0.82 
MHCII 0.57 0.05 0.09 0.02 
TCR 0.05 0.94 0.02 0.03 
IL 2R 0.55 0.81 0.07 0.56 
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Table 3.5. Geometric mean of fluorescence intensity of calves lymphocytic cells (+ standard error with 95% CI). (This is 
proportionate to the number of binding sites on the cells for the antibody. (Days are in reference to day of E. coli O157 inoculation, 
with controls sampled first day and BVD PIs sampled second day.) 
 
Antigen Group Day -3and-2 Day 19and20 Day 33and34
CD 2 Control 316.97+17.37 293.95+17.37 435.07+17.37 
 PIBVD 343.11+16.38 330.91+16.38 397.20+16.38 
CD4 Control 263.55+15.21 190.70+15.21 296.62+15.21 
 PIBVD 267.24+14.33 231.09+14.33 278.48+14.33 
CD8 Control 362.14+27.64 449.00+27.64 509.18+27.64 
 PIBVD 337.70+26.05 418.57+26.05 445.92+26.05 
CD11a Control 534.00+74.61 290.33+74.61 368.39+74.61 
 PIBVD 355.49+70.34 298.13+70.34 321.04+70.34 
CD14 Control 373.27+21.64 322.39+21.64 381.18+21.64 
 PIBVD 414.38+20.40 292.41+20.40 367.64+20.40 
CD21 Control 472.89+67.42 334.70+67.42 336.77+67.42 
 PIBVD 547.72+63.57 356.63+63.57 338.04+63.57 
CD44 Control 333.80+13.78 330.16+13.78 416.16+13.78 
 PIBVD 324.36+12.99 291.12+12.99 374.05+12.99 
 
 
 
 
 
 
 
 
Antigen Group Day -3and-2 Day 19and20 Day 33and34
CD62L Control 412.43+23.92 388.04+23.92 573.67+23.92 
 PIBVD 362.68+22.55 423.91+22.55 508.09+22.55 
MHCI Control 2240.11+287.57 1396.53+287.57 3032.79 
+287.57 
 PIBVD 2451.86+271.12 1649.42+271.12 2511.28 
+271.12 
MHCII Control 903.40+79.43 453.51+79.43 969.22+79.43 
 PIBVD 1112.70+74.88 453.42+74.88 957.54+74.88 
TCR Control 376.82+29.57 369.25+29.57 522.04+29.57 
 PIBVD 361.24+27.88 338.88+27.88 523.25+27.88 
IL2R Control 394.57+18.44 267.86+18.44 301.16+18.44 
 PIBVD 401.14+17.38 292.44+17.38 317.71+17.38 
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Table 3.6. P-values for percentages given in Table 3.5. (Days are in reference to day of 
E. coli O157 inoculation) p < 0.0047 is significant.  
Antigen Whole data set Day -2and-3 Day 19and20 Day 33and34 
CD2 0.54 0.23 0.13 0.12 
CD4 0.54 0.86 0.06 0.39 
CD8 0.18 0.52 0.43 0.10 
CD11a 0.24 0.09 0.94 0.65 
CD14 0.97 0.18 0.32 0.65 
CD21 0.53 0.42 0.81 0.99 
CD44 0.77 0.62 0.09 0.04 
CD62L 0.19 0.14 0.28 0.05 
MHCI 0.21 0.04 0.53 0.20 
MHCII 0.34 0.05 1.0 0.51 
TCR 0.58 0.70 0.46 0.98 
IL 2R 0.41 0.80 0.34 0.52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.1: Timeline of project details.  
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Figure 3.2:  Log10 average fecal shedding of E. coli O157:H7 from control and BVD-PI  
calves.
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